Epetraborole
Search documents
AN2 Therapeutics (NasdaqGS:ANTX) Earnings Call Presentation
2026-03-04 14:30
AN2Therapeutics INVESTOR WEBCAST EPETRABOROLE IN POLYCYTHEMIA VERA (PV) MARCH 4, 2026 Forward-Looking Statements This presentation contains forward-boking statements within the meaning of the Private Securities Lifigation Reform Act of 1995. Forward-looking statements expressed or im this presentation include, but are not limited to, statements regarding; the potential and competitive advantage of the Company's boron chemistry plaftorm; the addressable indications; the initiation of proof-of-concept clinica ...